Effects of intracameral injection of epinephrine and 2% lidocaine on pupil diameter, intraocular pressure, and cardiovascular parameters in healthy cats.


Journal

Veterinary ophthalmology
ISSN: 1463-5224
Titre abrégé: Vet Ophthalmol
Pays: England
ID NLM: 100887377

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 6 7 2018
medline: 29 5 2019
entrez: 6 7 2018
Statut: ppublish

Résumé

To investigate the effects of the intracameral injection of epinephrine and two doses of 2% lidocaine on pupil diameter (PD), intraocular pressure (IOP), heart rate (HR), and mean arterial pressure (MAP) in healthy cats. Five treatment groups were formed (10 cats/each). Animals received 0.2 mL of epinephrine, 0.2 or 0.3 mL of 2% lidocaine, or 0.2 mL of BSS. Cats were anesthetized, and all solutions were injected intracamerally. PD, IOP, HR, and MAP were assessed at baseline, following anterior chamber paracentesis (T0), and at every 5 minutes, until anesthesia was terminated (T60). PD and IOP continued to be assessed for 2 additional hours during recovery from anesthesia. In another group, cats were not anesthetized and one of the eyes was treated with one drop of 0.5% tropicamide to check for maximal pupil diameter. Faster onset and longer duration of sufficient mydriasis (>10 mm) were observed in epinephrine treatment group, when comparing with cats treated with both doses of lidocaine. Eyes treated with epinephrine achieved the largest maximum pupil diameter (mm) when comparing with eyes treated with 0.3 mL of lidocaine (11.01 ± 0.16), tropicamide (10.66 ± 0.17), and 0.2 mL of lidocaine (10.23 ± 0.12) (P < .0001). In all groups, IOP decreased significantly at T0, but tended to return to baseline at T60. HR and MAP did not change significantly during time and among treatments. The intracameral injection of 0.2 mL of 1:100 000 epinephrine and 0.3 mL of 2% lidocaine can be used as an alternative to tropicamide in healthy cats. Both treatments produced satisfactory and long-lasting mydriasis without adverse effects on IOP, HR, and MAP.

Identifiants

pubmed: 29975454
doi: 10.1111/vop.12588
doi:

Substances chimiques

Drug Combinations 0
Ophthalmic Solutions 0
Lidocaine 98PI200987
Epinephrine YKH834O4BH

Types de publication

Clinical Trial, Veterinary Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

276-283

Informations de copyright

© 2018 American College of Veterinary Ophthalmologists.

Auteurs

Tássia Moara Amorim (TM)

Faculdade de Medicina Veterinaria (FAVET), Universidade Federal de Mato Grosso (UFMT), Cuiaba, Brazil.

Nathalie Moro Bassil Dower (NMB)

Faculdade de Medicina Veterinaria (FAVET), Universidade Federal de Mato Grosso (UFMT), Cuiaba, Brazil.

Matias Bassinello Stocco (MB)

Faculdade de Medicina Veterinaria (FAVET), Universidade Federal de Mato Grosso (UFMT), Cuiaba, Brazil.

Laurem Hellem Pizoni (LH)

Faculdade de Medicina Veterinaria (FAVET), Universidade Federal de Mato Grosso (UFMT), Cuiaba, Brazil.

Alexandre Pinto Ribeiro (AP)

Faculdade de Medicina Veterinaria (FAVET), Universidade Federal de Mato Grosso (UFMT), Cuiaba, Brazil.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH